Wnt signaling as a regulator of memory T cells: implications for CAR-T cell therapy - Summary - MDSpire

Wnt signaling as a regulator of memory T cells: implications for CAR-T cell therapy

  • By

  • Tatiana Fourfouris

  • Ki Jun Lee

  • Samantha Hurwitz

  • Asher Ahdoot

  • Alexander Lee

  • Maiah Zarrabi

  • Michael Kahn

  • Yong-Mi Kim

  • May 13, 2026

Share

Objective:

To explore the function of Wnt/β-catenin signaling in T cell maturation and memory formation, and its implications for enhancing CAR-T cell therapy by improving persistence and efficacy.

Key Findings:
  • Wnt/β-catenin signaling is crucial for T cell memory programming and longevity.
  • Activation of this pathway can hinder effector differentiation and promote memory stem cell development.
  • Wnt-targeted strategies show clinical potential for enhancing CAR-T cell memory phenotypes and persistence.
Interpretation:

The findings suggest that manipulating Wnt signaling could improve the durability and effectiveness of CAR-T therapies by enhancing characteristics associated with memory T cells.

Limitations:
  • The molecular mechanisms influencing CAR-T cell persistence are not fully understood, particularly regarding the translation of basic science insights into clinical applications.
  • Further research is needed to clarify the specific pathways and mechanisms that need to be targeted for effective CAR-T cell therapy.
Conclusion:

Targeting Wnt signaling may provide a promising avenue for improving CAR-T cell therapy outcomes by enhancing memory T cell formation and persistence.

Original Source(s)

Wnt signaling as a regulator of memory T cells: implications for CAR-T cell therapy

  • by Tatiana Fourfouris, Ki Jun Lee, Samantha Hurwitz, Asher Ahdoot, Alexander Lee, Maiah Zarrabi, Michael Kahn, Yong-Mi Kim

  • May 13, 2026

Related Content

COA and Flatiron Health Study Finds Patients May Experience Longer Survival in Community Oncology Settings

Patients diagnosed with metastatic breast cancer and non–small cell lung cancer had longer survival compared to national benchmarks when treated in independent community oncology practices, according ...

Early-Onset Lung Cancer May Be Connected to Pesticide Contaminants

Dietary patterns in young patients with lung cancer suggest that many have higher dietary quality scores than average U.S. reference values, according to results from a study presented at the American...

Unique Phase I NSCLC Trial Sites Decreasing in United States

The number of unique clinical trial sites in the United States with phase I studies for patients with non–small cell lung cancer (NSCLC) decreased by 44% from 2020 to 2024, showing a significant conso...